Table 3.
SUVmax, %ΔSUVmax and size of NSCLC, metastases and benign nodules
| NSCLC (n = 74) | Metastases (n = 32) | Benign (n = 15) | ||||
|---|---|---|---|---|---|---|
| OSEM | BPL | OSEM | BPL | OSEM | BPL | |
| SUVmax | ||||||
| Mean | 6.5 | 9.5 | 3.7 | 6.7 | 2.9 | 4.0 |
| Median | 5.5 | 8.8 | 2.9 | 4.7 | 2.5 | 3.8 |
| Range | 1.0–19.4 | 1.1–30.7 | 0.5–12.1 | 0.5–26.1 | 1.0–6.3 | 1.0–9.1 |
| %ΔSUVmax | ||||||
| Mean | 46.6 % | 65.1 % | 35.0 % | |||
| Median | 39.8 % | 48.6 % | 39.7 % | |||
| Range | −16.7 to 190 % | −13.7 to 301 % | 0–85 % | |||
| Kruskall–Wallis p value | 0.393 | |||||
| Size (mm) | ||||||
| Mean | 15 | 17 | 14 | |||
| Median | 13.5 | 16.5 | 13 | |||
| Range | 3–28 | 5–28 | 8–24 | |||
| Kruskall–Wallis p value | 0.131 | |||||